John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 4,000 shares at $22.03 ($88K) on 2015-01-02, disclosed to the SEC on 2015-01-05.
Scheduled sale ($88k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.03 | 3,600 | $79K | 89.7% |
| 2 | $22.79 | 400 | $9K | 10.3% |
| Total | $22.11 avg | 4,000 | $88K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |